VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 207 filers reported holding VERACYTE INC in Q1 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,190 | -99.7% | 98,214 | +99.5% | 0.22% | +100.9% |
| Q3 2022 | $817,000 | +171.4% | 49,228 | +351.1% | 0.11% | +170.0% |
| Q1 2022 | $301,000 | -1.0% | 10,913 | -12.6% | 0.04% | -47.4% |
| Q1 2020 | $304,000 | +9.0% | 12,491 | +7.5% | 0.08% | +100.0% |
| Q3 2019 | $279,000 | -83.1% | 11,624 | -79.9% | 0.04% | -79.5% |
| Q2 2019 | $1,651,000 | +62.7% | 57,895 | +42.8% | 0.18% | +79.6% |
| Q1 2019 | $1,015,000 | +12.7% | 40,551 | -43.4% | 0.10% | -1.0% |
| Q4 2018 | $901,000 | +194.4% | 71,600 | +123.8% | 0.10% | +511.8% |
| Q3 2018 | $306,000 | +78.9% | 32,000 | +74.9% | 0.02% | +112.5% |
| Q2 2018 | $171,000 | -24.3% | 18,300 | -29.1% | 0.01% | -46.7% |
| Q3 2017 | $226,000 | -9.6% | 25,800 | -14.0% | 0.02% | -6.2% |
| Q2 2017 | $250,000 | +41.2% | 30,000 | +55.4% | 0.02% | +77.8% |
| Q1 2017 | $177,000 | +51.3% | 19,300 | +27.8% | 0.01% | +28.6% |
| Q4 2016 | $117,000 | – | 15,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |